AFM
BMY icon

Anson Funds Management’s Bristol-Myers Squibb BMY Stock Holding History

Anson Funds Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-360,700
Closed -$249K – 257
2020
Q4 		$249K Buy
+360,700
New +$22.2M 0.05% 145
2020
Q2 		– Sell
-23,700
Closed -$1.32M – 71
2020
Q1 		$1.32M Buy
23,700
+15,700
+196% +$960K 0.54% 31
2019
Q4 		$514K Buy
+8,000
New +$458K 0.6% 50

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Anson Funds Management's BMY Position: Q1 2021 in Review

Anson Funds Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 360,700 shares — an estimated $249K sold.

Anson Funds Management first reported a position in BMY in Q4 2019 and held it in 3 quarters. The position peaked at $1.32M in Q1 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Anson Funds Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Anson Funds Management sold 360,700 Bristol-Myers Squibb shares in Q1 2021, an estimated $249K.
  • Anson Funds Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 3 quarters.
  • Anson Funds Management's Bristol-Myers Squibb position peaked at $1.32M in Q1 2020.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.